Furthermore, resident glial cells are rapidly activated and trigger the release of proinflammatory cytokines such as interleukin-1 (IL-1β), tumor necrotic factor-alpha (TNF-α), and interleukin-6 (IL-6), which clinically compromise the prognosis of epilepsy [15, 16]. The gene discussed is IL1B; the disease is epilepsy.